Low Intracellular Iron Increases the Stability of Matriptase-2
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Matriptase-2 (MT2) is a type II transmembrane serine protease that is predominantly expressed in hepatocytes. It suppresses the expression of hepatic hepcidin, an iron regulatory hormone, by cleaving membrane hemojuvelin into an inactive form. Hemojuvelin is a bone morphogenetic protein (BMP) co-receptor. Here, we report that MT2 is up-regulated under iron deprivation. In HepG2 cells stably expressing the coding sequence of the MT2 gene, TMPRSS6, incubation with apo-transferrin or the membrane-impermeable iron chelator, deferoxamine mesylate salt, was able to increase MT2 levels. This increase did not result from the inhibition of MT2 shedding from the cells. Rather, studies using a membrane-permeable iron chelator, salicylaldehyde isonicotinoyl hydrazone, revealed that depletion of cellular iron was able to decrease the degradation of MT2 independently of internalization. We found that lack of the putative endocytosis motif in its cytoplasmic domain largely abolished the sensitivity of MT2 to iron depletion. Neither acute nor chronic iron deficiency was able to alter the association of Tmprss6 mRNA with polyribosomes in the liver of rats indicating a lack of translational regulation by low iron levels. Studies in mice showed that Tmprss6 mRNA was not regulated by iron nor the BMP-mediated signaling with no evident correlation with either Bmp6 mRNA or Id1 mRNA, a target of BMP signaling. These results suggest that regulation of MT2 occurs at the level of protein degradation rather than by changes in the rate of internalization and translational or transcriptional mechanisms and that the cytoplasmic domain of MT2 is necessary for its regulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Two to tango: Regulation of Mammalian iron metabolism
Hentze, M. W., Muckenthaler, M. U., Galy, B., & Camaschella, C. (2010) · Cell · doi:10.1016/j.cell.2010.06.028 · Cited by 2,120
Ganz, T., & Nemeth, E. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.01.014 · Cited by 1,282
Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression
Babitt, J. L., Huang, F. W., Wrighting, D. M., Xia, Y., Sidis, Y., Samad, T. A., Campagna, J. A., Chung, R. T., Schneyer, A. L., Woolf, C. J., et al. (2006) · Nature Genetics · doi:10.1038/ng1777 · Cited by 1,026 · cited 1×
“HJV acts as a co-receptor for BMP6 in hepatocytes to robustly induce hepcidin expression through the BMP-signaling pathway (24).”
BackgroundMutations in HFE2 cause iron overload in chromosome 1q–linked juvenile hemochromatosis
Papanikolaou, G., Samuels, M. E., Ludwig, E. H., MacDonald, M. L. E., Franchini, P. L., Dubé, M.-P., Andres, L., MacFarlane, J., Sakellaropoulos, N., Politou, M., et al. (2004) · Nature Genetics · doi:10.1038/ng1274 · Cited by 974 · cited 3×
“Similarly, a pronounced decrease in hepcidin expression and a severe iron overload are also present in mice with a global disruption or liver-specific disruption of both Hjv alleles (6, 7, 22, 25).”
BackgroundMutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis
Roetto, A., Papanikolaou, G., Politou, M., Alberti, F., Girelli, D., Christakis, J., Loukopoulos, D., & Camaschella, C. (2003) · Nature Genetics · doi:10.1038/ng1053 · Cited by 860
BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism
Andriopoulos Jr, B., Corradini, E., Xia, Y., Faasse, S. A., Chen, S., Grgurevic, L., Knutson, M. D., Pietrangelo, A., Vukicevic, S., Lin, H. Y., et al. (2009) · Nature Genetics · doi:10.1038/ng.335 · Cited by 769
Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA)
Finberg, K. E., Heeney, M. M., Campagna, D. R., Aydınok, Y., Pearson, H. A., Hartman, K. R., Mayo, M. M., Samuel, S. M., Strouse, J. J., Markianos, K., et al. (2008) · Nature Genetics · doi:10.1038/ng.130 · Cited by 675
Weinstein, D. A., Roy, C. N., Fleming, M. D., Loda, M. F., Wolfsdorf, J. I., & Andrews, N. C. (2002) · Blood · doi:10.1182/blood-2002-04-1260 · Cited by 632
The serine protease TMPRSS6 is required to sense iron deficiency
Du, X., She, E., Gelbart, T., Truksa, J., Lee, P., Xia, Y., Khovananth, K., Mudd, S., Mann, N., Moresco, E. M. Y., et al. (2008) · Science · doi:10.1126/science.1157121 · Cited by 578
Silvestri, L., Pagani, A., Nai, A., De Domenico, I., Kaplan, J., & Camaschella, C. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.09.012 · Cited by 555
Research works printed but not linked: 40
- De Domenico, 2008, The hepcidin-binding site on ferroportin is evolutionarily conserved, Cell Metab, 8, 146, 10.1016/j.cmet.2008.07.002 · DOI · Paper page
- Nemeth, 2004, Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization, Science, 306, 2090, 10.1126/science.1104742 · DOI · Paper page
- Huang, 2005, A mouse model of juvenile hemochromatosis, J. Clin. Invest, 115, 2187, 10.1172/JCI25049 · DOI · Paper page
- Niederkofler, 2005, Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload, J. Clin. Invest, 115, 2180, 10.1172/JCI25683 · DOI · Paper page
- Meynard, 2009, Lack of the bone morphogenetic protein BMP6 induces massive iron overload, Nat. Genet, 41, 478, 10.1038/ng.320 · DOI · Paper page
- Steinbicker, 2011, Perturbation of hepcidin expression by BMP type I receptor deletion induces iron overload in mice, Blood, 118, 4224, 10.1182/blood-2011-03-339952 · DOI · Paper page
- Lee, 2010, Neogenin inhibits HJV secretion and regulates BMP-induced hepcidin expression and iron homeostasis, Blood, 115, 3136, 10.1182/blood-2009-11-251199 · DOI
- Babitt, 2011, The molecular pathogenesis of hereditary hemochromatosis, Semin. Liver Dis, 31, 280, 10.1055/s-0031-1286059 · DOI
- Folgueras, 2008, The membrane-bound serine protease matriptase-2 (Tmprss6) is an essential regulator of iron homeostasis, Blood, 112, 2539, 10.1182/blood-2008-04-149773 · DOI · Paper page
- Velasco, 2002, Matriptase-2, a membrane-bound mosaic serine proteinase predominantly expressed in human liver and showing degrading activity against extracellular matrix proteins, J. Biol. Chem, 277, 37637, 10.1074/jbc.M203007200 · DOI · Paper page
- Zhang, 2011, Suppression of hepatic hepcidin expression in response to acute iron deprivation is associated with an increase of matripatase-2 protein, Blood, 117, 1687, 10.1182/blood-2010-06-287292 · DOI · Paper page
- Ramsay, 2009, Matriptase-2 (TMPRSS6): a proteolytic regulator of iron homeostasis, Haematologica, 94, 840, 10.3324/haematol.2008.001867 · DOI
- Béliveau, 2011, Essential role of endocytosis of the type II transmembrane serine protease TMPRSS6 in regulating its functionality, J. Biol. Chem, 286, 29035, 10.1074/jbc.M111.223461 · DOI
- Zhang, 2005, Interaction of hemojuvelin with neogenin results in iron accumulation in human embryonic kidney 293 cells, J. Biol. Chem, 280, 33885, 10.1074/jbc.M506207200 · DOI
- Zhang, 2009, Hemojuvelin-neogenin interaction is required for bone morphogenic protein-4-induced hepcidin expression, J. Biol. Chem, 284, 22580, 10.1074/jbc.M109.027318 · DOI
- Chen, 2011, Skeletal muscle hemojuvelin is dispensable for systemic iron homeostasis, Blood, 117, 6319, 10.1182/blood-2010-12-327957 · DOI
- Finberg, 2010, Downregulation of Bmp/Smad signaling by Tmprss6 is required for maintenance of systemic iron homeostasis, Blood, 115, 3817, 10.1182/blood-2009-05-224808 · DOI · Paper page
- Meynard, 2011, Regulation of TMPRSS6 by BMP6 and iron in human cells and mice, Blood, 118, 747, 10.1182/blood-2011-04-348698 · DOI
- Enns, 2012, Neogenin interacts with matriptase-2 to facilitate hemojuvelin cleavage, J. Biol. Chem, 287, 35104, 10.1074/jbc.M112.363937 · DOI
- Zhao, 2010, ZRT/IRT-like protein 14 (ZIP14) promotes the cellular assimilation of iron from transferrin, J. Biol. Chem, 285, 32141, 10.1074/jbc.M110.143248 · DOI · Paper page
- Uhles, 2007, Selective gene activation by spatial segregation of insulin receptor B signaling, FASEB J, 21, 1609, 10.1096/fj.06-7589com · DOI
- Zhang, 2007, Evidence that inhibition of hemojuvelin shedding in response to iron is mediated through neogenin, J. Biol. Chem, 282, 12547, 10.1074/jbc.M608788200 · DOI
- Anthony, 2001, Oral administration of leucine stimulates ribosomal protein mRNA translation but not global rates of protein synthesis in the liver of rats, J. Nutr, 131, 1171, 10.1093/jn/131.4.1171 · DOI
- Zhang, 2010, The role of hepatocyte hemojuvelin in the regulation of bone morphogenic protein-6 and hepcidin expression in vivo, J. Biol. Chem, 285, 16416, 10.1074/jbc.M110.109488 · DOI · Paper page
- Maxson, 2010, Matriptase-2- and proprotein convertase-cleaved forms of hemojuvelin have different roles in the down-regulation of hepcidin expression, J. Biol. Chem, 285, 39021, 10.1074/jbc.M110.183160 · DOI
- Young, 1997, Ceruloplasmin, transferrin and apotransferrin facilitate iron release from human liver cells, FEBS Lett, 411, 93, 10.1016/S0014-5793(97)00478-X · DOI · Paper page
- Baker, 1985, Transferrin and iron release from rat hepatocytes in culture, Am. J. Physiol, 248, G93
- Stirnberg, 2010, The proteolytic processing of the serine protease matriptase-2: identification of the cleavage sites required for its autocatalytic release from the cell surface, Biochem. J, 430, 87, 10.1042/BJ20091565 · DOI
- Zhao, 2014, An iron-regulated and glycosylation-dependent proteasomal degradation pathway for the plasma membrane metal transporter ZIP14, Proc. Natl. Acad. Sci. U.S.A, 111, 9175, 10.1073/pnas.1405355111 · DOI · Paper page
- Chen, 1998, Dietary iron intake rapidly influences iron regulatory proteins, ferritin subunits and mitochondrial aconitase in rat liver, J. Nutr, 128, 525, 10.1093/jn/128.3.525 · DOI
- Chen, 1997, Dietary iron intake modulates the activity of iron regulatory proteins and the abundance of ferritin and mitochondrial aconitase in rat liver, J. Nutr, 127, 238, 10.1093/jn/127.2.238 · DOI
- Schalinske, 1996, Phosphorylation and activation of both iron regulatory proteins 1 and 2 in HL-60 cells, J. Biol. Chem, 271, 7168, 10.1074/jbc.271.12.7168 · DOI
- Zhao, 2013, Iron regulation by hepcidin, J. Clin. Invest, 123, 2337, 10.1172/JCI67225 · DOI · Paper page
- Nai, 2010, Increased susceptibility to iron deficiency of Tmprss6-haploinsufficient mice, Blood, 116, 851, 10.1182/blood-2010-04-278655 · DOI
- Maurer, 2013, Hepatocyte growth factor activator inhibitor type 2 (HAI-2) modulates hepcidin expression by inhibiting the cell surface protease matriptase-2, Biochem. J, 450, 583, 10.1042/BJ20121518 · DOI
- Zhao, 2013, Crystal structures of matriptase in complex with its inhibitor hepatocyte growth factor activator inhibitor-1, J. Biol. Chem, 288, 11155, 10.1074/jbc.M113.454611 · doi:10.1074/jbc.m113.454611
- Szabo, 2009, Regulation of cell surface protease matriptase by HAI2 is essential for placental development, neural tube closure and embryonic survival in mice, Development, 136, 2653, 10.1242/dev.038430 · DOI
- Larsen, 2013, Hepatocyte growth factor activator inhibitor-2 prevents shedding of matriptase, Exp. Cell Res, 319, 918, 10.1016/j.yexcr.2013.01.008 · DOI
- Parr, 2010, Hepatocyte growth factor activation inhibitors- therapeutic potential in cancer, Anticancer Agents Med. Chem, 10, 47, 10.2174/1871520611009010047 · doi:10.2174/1871520611009010047
- Gkouvatsos, 2011, Conditional disruption of mouse HFE2 gene: maintenance of systemic iron homeostasis requires hepatic but not skeletal muscle hemojuvelin, Hepatology, 54, 1800, 10.1002/hep.24547 · DOI · Paper page
Cited by
Iron metabolism and iron disorders revisited in the hepcidin era
Camaschella, C., Nai, A., & Silvestri, L. (2020) · Haematologica · doi:10.3324/haematol.2019.232124 · Cited by 734
Regulation of the Iron Homeostatic Hormone Hepcidin
Sangkhae, V., & Nemeth, E. (2017) · Advances in Nutrition · doi:10.3945/an.116.013961 · Cited by 443
Liver iron sensing and body iron homeostasis
Wang, C.-Y., & Babitt, J. L. (2019) · Blood · doi:10.1182/blood-2018-06-815894 · Cited by 360
Hepcidin: regulation of the master iron regulator
Rishi, G., Wallace, D. F., & Subramaniam, V. N. (2015) · Bioscience Reports · doi:10.1042/bsr20150014 · Cited by 223
Ineffective erythropoiesis and regulation of iron status in iron loading anaemias
Camaschella, C., & Nai, A. (2016) · British Journal of Haematology · doi:10.1111/bjh.13820 · Cited by 172
Metadata
- Authors
- Zhao, N., Nizzi, C. P., Anderson, S. A., Wang, J., Ueno, A., Tsukamoto, H., Eisenstein, R. S., Enns, C. A., & Zhang, A.-S.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2015-02
- Volume
- 290
- Issue
- 7
- Pages
- 4432-4446
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2044404591
- Cited by
- 51
- References
- 13
- FWCI
- 3.67
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 2073 d)
- Funders
- National Institutes of Health (DK080765, DK102791, DK054488, K99DK104066, DK066600, P50AA11199, R24AA12885)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Low Intracellular Iron Increases the Stability of Matriptase-2. https://app.cochat.ai/papers/10.1074/jbc.m114.611913
- The paper
- Zhao, N., Nizzi, C. P., Anderson, S. A., Wang, J., Ueno, A., Tsukamoto, H., Eisenstein, R. S., Enns, C. A., & Zhang, A.-S. (2015). Low Intracellular Iron Increases the Stability of Matriptase-2. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.m114.611913
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.